CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo

Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that hu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virology 2017-01, Vol.91 (1)
Hauptverfasser: Teng, Ooiean, Chen, Szu-Ting, Hsu, Tsui-Ling, Sia, Sin Fun, Cole, Suzanne, Valkenburg, Sophie A, Hsu, Tzu-Yun, Zheng, Jian Teddy, Tu, Wenwei, Bruzzone, Roberto, Peiris, Joseph Sriyal Malik, Hsieh, Shie-Liang, Yen, Hui-Ling
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title Journal of virology
container_volume 91
creator Teng, Ooiean
Chen, Szu-Ting
Hsu, Tsui-Ling
Sia, Sin Fun
Cole, Suzanne
Valkenburg, Sophie A
Hsu, Tzu-Yun
Zheng, Jian Teddy
Tu, Wenwei
Bruzzone, Roberto
Peiris, Joseph Sriyal Malik
Hsieh, Shie-Liang
Yen, Hui-Ling
description Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin domain family 5 member A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of proinflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced levels of tumor necrosis factor alpha (TNF-α) and IP-10 but elevated alpha interferon (IFN-α) compared to those of wild-type mice. The heightened type I IFN response in the macrophages of CLEC5A-deficient mice was associated with upregulated TLR3 mRNA after treatment with double-stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of proinflammatory cytokines, decreased immune cell infiltration in the lungs, and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections. Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of proinflammatory cyto
doi_str_mv 10.1128/JVI.01813-16
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5165214</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1868304088</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-722ab3f2ffcdc06e720f90313e73cc5c57fe264c47254a207686aa9730246f7a3</originalsourceid><addsrcrecordid>eNqNkc2LFDEQxYMo7uzqzbPk6MFe8530RViacR2ZRRFdvIVMprIT6U7GTnphPPi32_vhojdPBfVe_ajHQ-gFJaeUMvPmw-XqlFBDeUPVI7SgpDWNlFQ8RgtCGGskN9-O0HEp3wmhQijxFB0xrVspuFigX9162cmz5gK20VXY4mXaueRhgFRxDrjuAK9S6N0wuJrHA_4MZZ9TARwTvjhAn-MWd9D3BXc51TFupgoF13x7NUH66fBlHKeCP7m6y1eQoo_1MKvz-jo_Q0-C6ws8v58n6Ou75ZfufbP-eL7qztaNF1TXRjPmNjywEPzWEwWakdASTjlo7r30UgdgSnihmRSOEa2Mcq7VnDChgnb8BL294-6nzQBbP6cbXW_3YxzceLDZRfuvkuLOXuVrK6mSjIoZ8OoeMOYfE5Rqh1j8nNslyFOx1CjDiSDG_IeVi7Ztjbyhvr6z-jGXMkJ4-IgSe9Oundu1t-1aqmb7y79TPJj_1Ml_A0_uoTU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1834999854</pqid></control><display><type>article</type><title>CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo</title><source>MEDLINE</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Teng, Ooiean ; Chen, Szu-Ting ; Hsu, Tsui-Ling ; Sia, Sin Fun ; Cole, Suzanne ; Valkenburg, Sophie A ; Hsu, Tzu-Yun ; Zheng, Jian Teddy ; Tu, Wenwei ; Bruzzone, Roberto ; Peiris, Joseph Sriyal Malik ; Hsieh, Shie-Liang ; Yen, Hui-Ling</creator><contributor>Perlman, Stanley</contributor><creatorcontrib>Teng, Ooiean ; Chen, Szu-Ting ; Hsu, Tsui-Ling ; Sia, Sin Fun ; Cole, Suzanne ; Valkenburg, Sophie A ; Hsu, Tzu-Yun ; Zheng, Jian Teddy ; Tu, Wenwei ; Bruzzone, Roberto ; Peiris, Joseph Sriyal Malik ; Hsieh, Shie-Liang ; Yen, Hui-Ling ; Perlman, Stanley</creatorcontrib><description>Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin domain family 5 member A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of proinflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced levels of tumor necrosis factor alpha (TNF-α) and IP-10 but elevated alpha interferon (IFN-α) compared to those of wild-type mice. The heightened type I IFN response in the macrophages of CLEC5A-deficient mice was associated with upregulated TLR3 mRNA after treatment with double-stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of proinflammatory cytokines, decreased immune cell infiltration in the lungs, and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections. Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of proinflammatory cytokines and chemokines in myeloid cells after influenza infections. CLEC5A-deficient mice infected with influenza virus showed reduced inflammation in the lungs and improved survival compared to that of the wild-type mice despite comparable viral loads. The survival difference was more prominent at a lower dose of inoculum. Collectively, our results suggest that dampening CLEC5A-mediated inflammatory responses in myeloid cells reduces immunopathogenesis after influenza infections.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.01813-16</identifier><identifier>PMID: 27795434</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Antibodies - pharmacology ; Chemokine CXCL10 - genetics ; Chemokine CXCL10 - immunology ; Gene Expression Regulation ; Hemagglutinin Glycoproteins, Influenza Virus - genetics ; Hemagglutinin Glycoproteins, Influenza Virus - immunology ; Host-Pathogen Interactions ; Humans ; Influenza A Virus, H1N1 Subtype - growth &amp; development ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza A Virus, H1N1 Subtype - pathogenicity ; Influenza A Virus, H5N1 Subtype - growth &amp; development ; Influenza A Virus, H5N1 Subtype - immunology ; Influenza A Virus, H5N1 Subtype - pathogenicity ; Interferon-alpha - genetics ; Interferon-alpha - immunology ; Lectins, C-Type - antagonists &amp; inhibitors ; Lectins, C-Type - genetics ; Lectins, C-Type - immunology ; Lentivirus - genetics ; Lentivirus - immunology ; Lung - drug effects ; Lung - immunology ; Lung - virology ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - virology ; Macrophages, Alveolar - drug effects ; Macrophages, Alveolar - immunology ; Macrophages, Alveolar - virology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Orthomyxoviridae ; Orthomyxoviridae Infections - genetics ; Orthomyxoviridae Infections - immunology ; Orthomyxoviridae Infections - mortality ; Orthomyxoviridae Infections - virology ; Pathogenesis and Immunity ; Primary Cell Culture ; Protein Binding ; Protein Isoforms - genetics ; Protein Isoforms - immunology ; Receptors, Cell Surface - antagonists &amp; inhibitors ; Receptors, Cell Surface - genetics ; Receptors, Cell Surface - immunology ; RNA, Small Interfering - genetics ; RNA, Small Interfering - metabolism ; Survival Analysis ; Toll-Like Receptor 3 - genetics ; Toll-Like Receptor 3 - immunology ; Tumor Necrosis Factor-alpha - genetics ; Tumor Necrosis Factor-alpha - immunology</subject><ispartof>Journal of virology, 2017-01, Vol.91 (1)</ispartof><rights>Copyright © 2016 Teng et al.</rights><rights>Copyright © 2016 Teng et al. 2016 Teng et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-722ab3f2ffcdc06e720f90313e73cc5c57fe264c47254a207686aa9730246f7a3</citedby><cites>FETCH-LOGICAL-c417t-722ab3f2ffcdc06e720f90313e73cc5c57fe264c47254a207686aa9730246f7a3</cites><orcidid>0000-0003-2493-3609</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165214/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165214/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27795434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Perlman, Stanley</contributor><creatorcontrib>Teng, Ooiean</creatorcontrib><creatorcontrib>Chen, Szu-Ting</creatorcontrib><creatorcontrib>Hsu, Tsui-Ling</creatorcontrib><creatorcontrib>Sia, Sin Fun</creatorcontrib><creatorcontrib>Cole, Suzanne</creatorcontrib><creatorcontrib>Valkenburg, Sophie A</creatorcontrib><creatorcontrib>Hsu, Tzu-Yun</creatorcontrib><creatorcontrib>Zheng, Jian Teddy</creatorcontrib><creatorcontrib>Tu, Wenwei</creatorcontrib><creatorcontrib>Bruzzone, Roberto</creatorcontrib><creatorcontrib>Peiris, Joseph Sriyal Malik</creatorcontrib><creatorcontrib>Hsieh, Shie-Liang</creatorcontrib><creatorcontrib>Yen, Hui-Ling</creatorcontrib><title>CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin domain family 5 member A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of proinflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced levels of tumor necrosis factor alpha (TNF-α) and IP-10 but elevated alpha interferon (IFN-α) compared to those of wild-type mice. The heightened type I IFN response in the macrophages of CLEC5A-deficient mice was associated with upregulated TLR3 mRNA after treatment with double-stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of proinflammatory cytokines, decreased immune cell infiltration in the lungs, and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections. Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of proinflammatory cytokines and chemokines in myeloid cells after influenza infections. CLEC5A-deficient mice infected with influenza virus showed reduced inflammation in the lungs and improved survival compared to that of the wild-type mice despite comparable viral loads. The survival difference was more prominent at a lower dose of inoculum. Collectively, our results suggest that dampening CLEC5A-mediated inflammatory responses in myeloid cells reduces immunopathogenesis after influenza infections.</description><subject>Animals</subject><subject>Antibodies - pharmacology</subject><subject>Chemokine CXCL10 - genetics</subject><subject>Chemokine CXCL10 - immunology</subject><subject>Gene Expression Regulation</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - genetics</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - immunology</subject><subject>Host-Pathogen Interactions</subject><subject>Humans</subject><subject>Influenza A Virus, H1N1 Subtype - growth &amp; development</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza A Virus, H1N1 Subtype - pathogenicity</subject><subject>Influenza A Virus, H5N1 Subtype - growth &amp; development</subject><subject>Influenza A Virus, H5N1 Subtype - immunology</subject><subject>Influenza A Virus, H5N1 Subtype - pathogenicity</subject><subject>Interferon-alpha - genetics</subject><subject>Interferon-alpha - immunology</subject><subject>Lectins, C-Type - antagonists &amp; inhibitors</subject><subject>Lectins, C-Type - genetics</subject><subject>Lectins, C-Type - immunology</subject><subject>Lentivirus - genetics</subject><subject>Lentivirus - immunology</subject><subject>Lung - drug effects</subject><subject>Lung - immunology</subject><subject>Lung - virology</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - virology</subject><subject>Macrophages, Alveolar - drug effects</subject><subject>Macrophages, Alveolar - immunology</subject><subject>Macrophages, Alveolar - virology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Orthomyxoviridae</subject><subject>Orthomyxoviridae Infections - genetics</subject><subject>Orthomyxoviridae Infections - immunology</subject><subject>Orthomyxoviridae Infections - mortality</subject><subject>Orthomyxoviridae Infections - virology</subject><subject>Pathogenesis and Immunity</subject><subject>Primary Cell Culture</subject><subject>Protein Binding</subject><subject>Protein Isoforms - genetics</subject><subject>Protein Isoforms - immunology</subject><subject>Receptors, Cell Surface - antagonists &amp; inhibitors</subject><subject>Receptors, Cell Surface - genetics</subject><subject>Receptors, Cell Surface - immunology</subject><subject>RNA, Small Interfering - genetics</subject><subject>RNA, Small Interfering - metabolism</subject><subject>Survival Analysis</subject><subject>Toll-Like Receptor 3 - genetics</subject><subject>Toll-Like Receptor 3 - immunology</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc2LFDEQxYMo7uzqzbPk6MFe8530RViacR2ZRRFdvIVMprIT6U7GTnphPPi32_vhojdPBfVe_ajHQ-gFJaeUMvPmw-XqlFBDeUPVI7SgpDWNlFQ8RgtCGGskN9-O0HEp3wmhQijxFB0xrVspuFigX9162cmz5gK20VXY4mXaueRhgFRxDrjuAK9S6N0wuJrHA_4MZZ9TARwTvjhAn-MWd9D3BXc51TFupgoF13x7NUH66fBlHKeCP7m6y1eQoo_1MKvz-jo_Q0-C6ws8v58n6Ou75ZfufbP-eL7qztaNF1TXRjPmNjywEPzWEwWakdASTjlo7r30UgdgSnihmRSOEa2Mcq7VnDChgnb8BL294-6nzQBbP6cbXW_3YxzceLDZRfuvkuLOXuVrK6mSjIoZ8OoeMOYfE5Rqh1j8nNslyFOx1CjDiSDG_IeVi7Ztjbyhvr6z-jGXMkJ4-IgSe9Oundu1t-1aqmb7y79TPJj_1Ml_A0_uoTU</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Teng, Ooiean</creator><creator>Chen, Szu-Ting</creator><creator>Hsu, Tsui-Ling</creator><creator>Sia, Sin Fun</creator><creator>Cole, Suzanne</creator><creator>Valkenburg, Sophie A</creator><creator>Hsu, Tzu-Yun</creator><creator>Zheng, Jian Teddy</creator><creator>Tu, Wenwei</creator><creator>Bruzzone, Roberto</creator><creator>Peiris, Joseph Sriyal Malik</creator><creator>Hsieh, Shie-Liang</creator><creator>Yen, Hui-Ling</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2493-3609</orcidid></search><sort><creationdate>20170101</creationdate><title>CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo</title><author>Teng, Ooiean ; Chen, Szu-Ting ; Hsu, Tsui-Ling ; Sia, Sin Fun ; Cole, Suzanne ; Valkenburg, Sophie A ; Hsu, Tzu-Yun ; Zheng, Jian Teddy ; Tu, Wenwei ; Bruzzone, Roberto ; Peiris, Joseph Sriyal Malik ; Hsieh, Shie-Liang ; Yen, Hui-Ling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-722ab3f2ffcdc06e720f90313e73cc5c57fe264c47254a207686aa9730246f7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Antibodies - pharmacology</topic><topic>Chemokine CXCL10 - genetics</topic><topic>Chemokine CXCL10 - immunology</topic><topic>Gene Expression Regulation</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - genetics</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - immunology</topic><topic>Host-Pathogen Interactions</topic><topic>Humans</topic><topic>Influenza A Virus, H1N1 Subtype - growth &amp; development</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza A Virus, H1N1 Subtype - pathogenicity</topic><topic>Influenza A Virus, H5N1 Subtype - growth &amp; development</topic><topic>Influenza A Virus, H5N1 Subtype - immunology</topic><topic>Influenza A Virus, H5N1 Subtype - pathogenicity</topic><topic>Interferon-alpha - genetics</topic><topic>Interferon-alpha - immunology</topic><topic>Lectins, C-Type - antagonists &amp; inhibitors</topic><topic>Lectins, C-Type - genetics</topic><topic>Lectins, C-Type - immunology</topic><topic>Lentivirus - genetics</topic><topic>Lentivirus - immunology</topic><topic>Lung - drug effects</topic><topic>Lung - immunology</topic><topic>Lung - virology</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - virology</topic><topic>Macrophages, Alveolar - drug effects</topic><topic>Macrophages, Alveolar - immunology</topic><topic>Macrophages, Alveolar - virology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Orthomyxoviridae</topic><topic>Orthomyxoviridae Infections - genetics</topic><topic>Orthomyxoviridae Infections - immunology</topic><topic>Orthomyxoviridae Infections - mortality</topic><topic>Orthomyxoviridae Infections - virology</topic><topic>Pathogenesis and Immunity</topic><topic>Primary Cell Culture</topic><topic>Protein Binding</topic><topic>Protein Isoforms - genetics</topic><topic>Protein Isoforms - immunology</topic><topic>Receptors, Cell Surface - antagonists &amp; inhibitors</topic><topic>Receptors, Cell Surface - genetics</topic><topic>Receptors, Cell Surface - immunology</topic><topic>RNA, Small Interfering - genetics</topic><topic>RNA, Small Interfering - metabolism</topic><topic>Survival Analysis</topic><topic>Toll-Like Receptor 3 - genetics</topic><topic>Toll-Like Receptor 3 - immunology</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teng, Ooiean</creatorcontrib><creatorcontrib>Chen, Szu-Ting</creatorcontrib><creatorcontrib>Hsu, Tsui-Ling</creatorcontrib><creatorcontrib>Sia, Sin Fun</creatorcontrib><creatorcontrib>Cole, Suzanne</creatorcontrib><creatorcontrib>Valkenburg, Sophie A</creatorcontrib><creatorcontrib>Hsu, Tzu-Yun</creatorcontrib><creatorcontrib>Zheng, Jian Teddy</creatorcontrib><creatorcontrib>Tu, Wenwei</creatorcontrib><creatorcontrib>Bruzzone, Roberto</creatorcontrib><creatorcontrib>Peiris, Joseph Sriyal Malik</creatorcontrib><creatorcontrib>Hsieh, Shie-Liang</creatorcontrib><creatorcontrib>Yen, Hui-Ling</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teng, Ooiean</au><au>Chen, Szu-Ting</au><au>Hsu, Tsui-Ling</au><au>Sia, Sin Fun</au><au>Cole, Suzanne</au><au>Valkenburg, Sophie A</au><au>Hsu, Tzu-Yun</au><au>Zheng, Jian Teddy</au><au>Tu, Wenwei</au><au>Bruzzone, Roberto</au><au>Peiris, Joseph Sriyal Malik</au><au>Hsieh, Shie-Liang</au><au>Yen, Hui-Ling</au><au>Perlman, Stanley</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>91</volume><issue>1</issue><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin domain family 5 member A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of proinflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced levels of tumor necrosis factor alpha (TNF-α) and IP-10 but elevated alpha interferon (IFN-α) compared to those of wild-type mice. The heightened type I IFN response in the macrophages of CLEC5A-deficient mice was associated with upregulated TLR3 mRNA after treatment with double-stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of proinflammatory cytokines, decreased immune cell infiltration in the lungs, and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections. Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of proinflammatory cytokines and chemokines in myeloid cells after influenza infections. CLEC5A-deficient mice infected with influenza virus showed reduced inflammation in the lungs and improved survival compared to that of the wild-type mice despite comparable viral loads. The survival difference was more prominent at a lower dose of inoculum. Collectively, our results suggest that dampening CLEC5A-mediated inflammatory responses in myeloid cells reduces immunopathogenesis after influenza infections.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>27795434</pmid><doi>10.1128/JVI.01813-16</doi><orcidid>https://orcid.org/0000-0003-2493-3609</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2017-01, Vol.91 (1)
issn 0022-538X
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5165214
source MEDLINE; PubMed Central; EZB Electronic Journals Library
subjects Animals
Antibodies - pharmacology
Chemokine CXCL10 - genetics
Chemokine CXCL10 - immunology
Gene Expression Regulation
Hemagglutinin Glycoproteins, Influenza Virus - genetics
Hemagglutinin Glycoproteins, Influenza Virus - immunology
Host-Pathogen Interactions
Humans
Influenza A Virus, H1N1 Subtype - growth & development
Influenza A Virus, H1N1 Subtype - immunology
Influenza A Virus, H1N1 Subtype - pathogenicity
Influenza A Virus, H5N1 Subtype - growth & development
Influenza A Virus, H5N1 Subtype - immunology
Influenza A Virus, H5N1 Subtype - pathogenicity
Interferon-alpha - genetics
Interferon-alpha - immunology
Lectins, C-Type - antagonists & inhibitors
Lectins, C-Type - genetics
Lectins, C-Type - immunology
Lentivirus - genetics
Lentivirus - immunology
Lung - drug effects
Lung - immunology
Lung - virology
Macrophages - drug effects
Macrophages - immunology
Macrophages - virology
Macrophages, Alveolar - drug effects
Macrophages, Alveolar - immunology
Macrophages, Alveolar - virology
Mice
Mice, Inbred C57BL
Mice, Knockout
Orthomyxoviridae
Orthomyxoviridae Infections - genetics
Orthomyxoviridae Infections - immunology
Orthomyxoviridae Infections - mortality
Orthomyxoviridae Infections - virology
Pathogenesis and Immunity
Primary Cell Culture
Protein Binding
Protein Isoforms - genetics
Protein Isoforms - immunology
Receptors, Cell Surface - antagonists & inhibitors
Receptors, Cell Surface - genetics
Receptors, Cell Surface - immunology
RNA, Small Interfering - genetics
RNA, Small Interfering - metabolism
Survival Analysis
Toll-Like Receptor 3 - genetics
Toll-Like Receptor 3 - immunology
Tumor Necrosis Factor-alpha - genetics
Tumor Necrosis Factor-alpha - immunology
title CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T20%3A24%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CLEC5A-Mediated%20Enhancement%20of%20the%20Inflammatory%20Response%20in%20Myeloid%20Cells%20Contributes%20to%20Influenza%20Virus%20Pathogenicity%20In%20Vivo&rft.jtitle=Journal%20of%20virology&rft.au=Teng,%20Ooiean&rft.date=2017-01-01&rft.volume=91&rft.issue=1&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.01813-16&rft_dat=%3Cproquest_pubme%3E1868304088%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1834999854&rft_id=info:pmid/27795434&rfr_iscdi=true